NCS7
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
07/28/2026
Back to search
Official data from USPTO
AUCMIST
This trademark appears in the official USPTO history.
Even when the status is closed, the history helps calibrate risk, avoid repeating mistakes, and define a safe naming strategy.
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILEDType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Case type
Application and registration
Recorded events
17
Latest update
08/18/2026
Trademark type
Word
Nice classes
5
Filing date
11/11/2025
Registration date
06/09/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2026
Last transaction
08/18/2026
Responsible office
United States Patent and Trademark Office
Status code
711
Official register
Principal Register
First use anywhere
09/25/2025
First use in commerce
09/25/2025
Drawing code
4
Owner type
99
Owner location
Shanghai, CN
Examiner
JOHNSON, JAYLEN SYLVIA
Current location
Historical data usage
Holders and representatives
Holders
Shanghai Aucta Pharmaceuticals Co., Ltd.
Representatives
Christopher D. Olszyk, Jr. Fox Rothschild LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Ophthalmologic preparations; Allergy medication; Bronchodilators; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical agents affecting metabolism; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Chemical reagents for medical use; Pharmaceutical preparationsappetite suppressants
Publications
History of USPTO decisions and trademark events.
17 publications found
C7..
CANCELLED SECTION 7-TOTAL
07/28/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/28/2026
C7RF
REQUEST FOR SECT 7 TOTAL SURRENDER FILED
06/24/2026
ES7S
TEAS SECTION 7 SURRENDER RECEIVED
06/24/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/17/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/17/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
06/09/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2026
PUBO
PUBLISHED FOR OPPOSITION
04/21/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/15/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2026
DOCK
ASSIGNED TO EXAMINER
03/20/2026
MAFR
APPLICATION FILING RECEIPT MAILED
11/11/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/11/2025
NWAP
NEW APPLICATION ENTERED
11/11/2025
Continuous trademark protection
Get notified about every new filing that threatens AUCMIST or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.